Mai Ya

Hordeum vulgare

Also known as: Barley(English) Barley Sprout(English) Malted Barley(English) Mai Ya(Chinese (Pinyin)) 麦芽(Chinese)

Bakuga麦芽 バクガ Maega麥芽 맥아 Mạch nha

Updated October 23, 2026 · Not yet clinically reviewed

Mai Ya
Thomé, Flora von Deutschland · public domain, via Wikimedia Commons

Safety at a glance

High risk

Breastfeeding: avoid — suppresses lactation (esp. high dose)

Caution

4 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
relieving food stagnation
Temperature
Neutral
Taste
Sweet
Channels
Liver,Spleen,Stomach

Functions

Reduces Food Stagnation, improves digestion and strengthens the Stomach; Inhibits lactation; Facilitates the smooth flow of Liver Qi

Traditional uses

Mai Ya (barley sprout, malt) is a mild herb used in Chinese medicine to reduce food stagnation from starchy foods, grains, and fruit, to stimulate appetite in Spleen Qi deficiency with weak digestion, and to treat poorly digested milk in infants. At high doses, it disperses Liver Qi stagnation and is traditionally used to suppress lactation when weaning. It is a gentle, food-grade herb frequently combined with Shan Zha and Shen Qu as the classical digestive tonic trio.

Western herbalism

Properties: carminative, digestive, tonic, demulcent

Pharmacological effects

  • Digestive: Enzymes aid carbohydrate and protein digestion; heat-labile amylase makes decoction ~1/3 and browned herb ~1/6 the activity of powder; decoction mildly increased gastric acid and pepsin.
  • Hypoglycemic: Oral aqueous extract lowered blood glucose in rabbits and normal humans; a 5% injection from brewing residues (200 mg in rabbits) lowered glucose >40%, reversible in 7 h.
  • Miscellaneous (hordenine): Hordenine is sympathomimetic (cardiac stimulation, vasoconstriction, bronchodilation, intestinal inhibition) but content too low and poorly water-soluble to matter.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 397.

Formulas using this herb

20 of 20 formulas

Botanical

Hordeum vulgare is an annual grass growing 60-120 cm tall, with hollow, jointed culms and flat, linear leaves 10-20 cm long with prominent auricles that clasp the stem. The inflorescence is a dense spike bearing three spikelets at each rachis node (the characteristic barley arrangement). Each spikelet contains one grain (caryopsis) and is often associated with long, stiff awns. In TCM, the germinated grain (Mai Ya) is used, made by sprouting the barley grain.

Family
Poaceae
Pharmaceutical name
Fructus Hordei Germinatus
Parts used
seed
Plant type
grass
Native region
Palestine
Conservation status
not_evaluated

Habitat

Cultivated in fields throughout temperate regions worldwide; one of the oldest and most widely grown cereal crops. Native to the Fertile Crescent region of the Middle East.

Conservation notes

Hordeum vulgare is one of the world most widely cultivated cereal crops. It is a domesticated species. Wild barley (H. vulgare subsp. spontaneum) is found in the Middle East and Central Asia. No conservation concerns for the cultivated form.

Constituents

Hordenine (N,N-dimethyltyramine)

Phenethylamine alkaloid · total alkaloids of germinated barley have been measured at about 42.7 mg hordenine-equivalent per gram of drug by acid-dye colorimetry; that figure is a total-alkaloid estimate expressed as hordenine, not the hordenine content itself

The compound that makes Mai Ya pharmacologically distinctive rather than merely digestive. Hordenine is a functionally selective dopamine D2 receptor agonist; D2 agonism at the anterior pituitary suppresses prolactin release, which is the mechanism of both the traditional lactation-suppressing use at high dose and the modern Chinese use for hyperprolactinaemia. Total alkaloid content of malt varies with sprout length, reported to peak at about 0.75 cm of bud, so the germination endpoint changes the potency of this action.

N-Methyltyramine

Phenethylamine alkaloid

The other dopamine D2 receptor agonist identified in germinated barley and tracked through the brewing process alongside hordenine. It contributes to the same prolactin-suppressing pharmacology and to the total alkaloid figure quoted for the drug.

Gramine

Indole alkaloid

A barley alkaloid quantified together with hordenine by HPLC in the barley chemical-ecology literature. It is principally a seedling and leaf constituent rather than a marker of the malted grain, so it should not be presented as a constituent of the medicinal sprout without batch-specific data.

alpha-Amylase and beta-amylase (diastase)

Starch-hydrolysing enzyme

Induced by germination and the conventional explanation for the food-stagnation indication. Being proteins they are heat-labile: raw or lightly stir-fried Mai Ya retains them, heavily stir-fried (Chao Mai Ya) and charred (Mai Ya Tan) material progressively loses them. This is the practical reason the raw drug is preferred where digestion of starchy food stagnation is the aim.

(1,3;1,4)-beta-D-Glucan

Soluble dietary fibre polysaccharide

The barley fibre with the best human evidence of any constituent here: a meta-analysis of randomised controlled trials found barley beta-glucan lowers LDL cholesterol and total cholesterol. The trials used barley foods at food-scale intakes, not the medicinal dose of Mai Ya, so this supports barley as a food rather than the herb as a lipid drug.

Hordein

Prolamin storage protein (gluten)

Barley's gluten protein. Mai Ya is therefore not gluten-free and is unsafe in coeliac disease and in non-coeliac gluten sensitivity, however it is processed - malting does not remove hordein. Where a sprouted-grain digestive is needed in a coeliac patient, millet sprout (Su Ya / Gu Ya, Setaria italica) is the substitution that avoids the problem.

Maillard reaction products of stir-frying

Thermally generated condensation products

Formed when the sprout is stir-fried, and shown to promote the intestinal absorption of the drug's active ingredients. This gives a chemical reason why processed Mai Ya is not simply a weaker version of the raw drug: stir-frying destroys enzyme activity but improves absorption of the small-molecule actives.

Drug interactions

Breastfeeding and galactagogue therapy (including domperidone and metoclopramide used for milk supply)

Major · suppression of milk production; loss of an established milk supply is not readily reversible · Evidence level: Probable

At the high doses recorded in Chinese practice, conventionally 30 to 120 g, Mai Ya suppresses prolactin secretion and reduces milk production - this is a deliberate therapeutic use for weaning and for breast distension, not an incidental effect. The mechanism is dopamine D2 receptor agonism by hordenine and N-methyltyramine at the pituitary lactotrophs. In hyperprolactinaemic rats, malt of different bud lengths lowered serum prolactin, reduced the number of prolactin-positive pituitary cells and their mRNA expression, and raised hypothalamic dopamine D1 and D2 receptor numbers. Domperidone and metoclopramide raise milk supply by the opposite action, D2 blockade, so the two are directly pharmacodynamically opposed. Note that the small quantities of malt in food and beer are not the same exposure as a 60 to 120 g decoction dose.

Clinical note: Do not prescribe Mai Ya at digestive doses without asking whether the patient is breastfeeding or wishes to be, and avoid it entirely in a mother establishing supply. When used deliberately for weaning or for engorgement, say so explicitly to the patient - and understand the dose direction: low doses are used in Chinese practice to promote lactation while high doses suppress it, so an imprecise dose can produce the opposite of the intended effect.

Antipsychotics and other dopamine D2 antagonists (risperidone, amisulpride, sulpiride, haloperidol, metoclopramide)

Moderate · pharmacodynamic opposition at the D2 receptor; blunting of the drug-induced prolactin rise, and theoretically of antipsychotic effect · Evidence level: Possible

Total barley maiya alkaloids prevented the prolactin elevation caused by antipsychotic drugs in rats and reduced dopamine receptor D2 expression through epigenetic mechanisms, and a separate study showed the alkaloids inhibit prolactin secretion by acting on D2 receptor and protein kinase A targets. This has been proposed as a use rather than a hazard - treating antipsychotic-induced hyperprolactinaemia - but the same D2 agonism is in principle opposed to the antipsychotic's mechanism. All the evidence is rodent and cell-based; no human co-administration study exists.

Clinical note: Do not add or remove Mai Ya at high dose in a psychiatrically stable patient on an antipsychotic without telling the prescriber. If it is being used for drug-induced hyperprolactinaemia, that should be a shared decision with the psychiatrist, not a substitution for reviewing the antipsychotic.

Dopamine agonists (bromocriptine, cabergoline)

Moderate · additive prolactin suppression · Evidence level: Theoretical

Both act at the D2 receptor in the same direction as hordenine, so the effects should add. Hordenine also showed an antiprolactinoma effect in rats through inhibition of MAPK signalling, the same indication cabergoline is used for. No human data on the combination, and the potency of dietary or medicinal hordenine relative to cabergoline is unknown, so this is graded theoretical.

Clinical note: Not a reason to avoid the combination, but check prolactin if a patient on cabergoline or bromocriptine starts high-dose Mai Ya, and do not assume the herb can replace the drug in macroprolactinoma.

Monoamine oxidase inhibitors (phenelzine, tranylcypromine, moclobemide, linezolid)

Theoretical · possible pressor response · Evidence level: Theoretical

Hordenine and N-methyltyramine are N-methylated tyramine derivatives, and tyramine itself is the classic substrate behind the hypertensive reaction to MAO inhibitors. Whether these particular methylated analogues produce a clinically meaningful pressor effect at malt doses has not been tested, so this is an inference from chemical class rather than a documented interaction, and it is recorded here only because the class of compound is the one that matters for MAOI diet advice.

Clinical note: Reasonable to avoid high-dose Mai Ya in a patient on a non-selective MAO inhibitor, alongside the standard tyramine restrictions, rather than to reassure them that the herb is unrelated.

Dosage

FormAmountFrequencyPopulationNotes
decoction10–15 gdailyadult
中国药典 2020年版 一部 【麦芽】【用法与用量】10~15g;回乳炒用60g。 — Chinese Pharmacopoeia 2020, Vol. I. Use fried (chao) form to reduce food stagnation.

Dui yao: classical pairings

Mai Ya + Gu Ya谷芽

Gently reduce food stagnation and awaken the spleen and stomach without harming stomach qi.

Poor appetite and indigestion, especially after illness or with spleen deficiency.

Named pairing — Lü Jingshan, Shi Jinmo Dui Yao

Evidence

Study design on record, not certainty of outcome.

Systematic review / meta-analysis
1
In vitro / animal
6

β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials

AbuMweis S S; Jew S; Ames N P · European Journal of Clinical Nutrition · 2010 · systematic review

Systematic review / meta-analysis · Verified

Pooled randomised controlled trials of barley beta-glucan and found significant reductions in total and LDL cholesterol. The only human randomised evidence attaching to any constituent of this drug, but it concerns barley as a food at fibre-scale intakes and does not validate Mai Ya as a lipid-lowering herb.

doi:10.1038/ejcn.2010.178

Total barley maiya alkaloids inhibit prolactin secretion by acting on dopamine D2 receptor and protein kinase A targets

Gong Xiaoyun; Tao Jiahan; Wang Yanming; Wu Jinhu; An Jing; Meng Junhua; Wang Xiong; Chen Yonggang; Zou Jili · Journal of Ethnopharmacology · 2021 · animal

In vitro / animal · Verified

The total alkaloid fraction of barley maiya suppressed prolactin secretion, with the effect traced to dopamine D2 receptor engagement and downstream protein kinase A signalling. This is the mechanistic core of the lactation-suppressing action and it studied Hordeum vulgare malt specifically.

doi:10.1016/j.jep.2021.113994

Total Barley Maiya Alkaloids Prevent Increased Prolactin Levels Caused by Antipsychotic Drugs and Reduce Dopamine Receptor D2 via Epigenetic Mechanisms

Cao Yu-Ling; Zhu Li; Zhang Hong; Meng Jun-Hua; Wu Hua-Jun; Wang Xiong; Wu Jin-Hu; Zou Ji-Li; Fang Mao-Sheng; An Jing; Chen Yong-Gang · Frontiers in Pharmacology · 2022 · animal

In vitro / animal · Not yet verified

Barley maiya alkaloids blocked the prolactin rise produced by antipsychotic drugs in rats and downregulated dopamine receptor D2 through epigenetic mechanisms. Basis for the antipsychotic interaction recorded above, in both its therapeutic and its cautionary reading; rodent data only.

doi:10.3389/fphar.2022.888522

Antiprolactinoma Effect of Hordenine by Inhibiting MAPK Signaling Pathway Activation in Rats

Wang Xiong; Guo Run-zhu; Ma Li; Ding Qiao-yan; Meng Jun-hua; Chen Yong-gang; Wu Jin-hu · Evidence-Based Complementary and Alternative Medicine · 2020 · animal

In vitro / animal · Not yet verified

Isolated hordenine, the principal barley malt alkaloid, reduced prolactinoma growth in rats with suppression of MAPK pathway activation. Attributes the drug's endocrine effect to a single identified compound; rat study, no human evidence.

doi:10.1155/2020/3107290

Monitoring of the dopamine D2 receptor agonists hordenine and N-methyltyramine during the brewing process and in commercial beer samples

Sommer Thomas; Dlugash Gelena; Hübner Harald; Gmeiner Peter; Pischetsrieder Monika · Food Chemistry · 2019 · in vitro

In vitro / animal · Not yet verified

Confirms hordenine and N-methyltyramine as dopamine D2 receptor agonists and quantifies them through malting and brewing. Establishes that the D2 activity is a property of germinated barley itself and survives processing, which is what makes the endocrine effect of Mai Ya credible rather than merely traditional.

doi:10.1016/j.foodchem.2018.10.067

UPLC-Q-TOF-MS/MS analysis on the chemical composition of malts under different germination cycles and prepared with different processing methods

Zou Jili; Wu Siran; Sheng Bi; An Jing; Meng Junhua; Wang Xiong; Tao Jiahan; Han Wang; Zhao Lin; Xu Hanlin; Chen Yonggang · Fitoterapia · 2023 · in vitro

In vitro / animal · Not yet verified

Compared malt composition across germination times and across raw, stir-fried and charred preparations. Provides the chemical basis for treating raw Mai Ya, Chao Mai Ya and Mai Ya Tan as distinct drugs rather than interchangeable grades of one.

doi:10.1016/j.fitote.2022.105313

Promoting effect of the Maillard reaction products produced during the stir-frying process of Hordei Fructus Germinatus on the intestinal absorption of active ingredients in Hordei Fructus Germinatus

Wu Lu; Tan Li Xia; Gong Fen Fang; Xia Yu; Chu Rui Ge; Yang Hua Sheng · Food Science and Biotechnology · 2021 · in vitro

In vitro / animal · Not yet verified

Maillard reaction products formed during stir-frying of germinated barley increased the intestinal absorption of the drug's active constituents. Explains why the processed drug is not simply a heat-degraded version of the raw one, and supports the traditional practice of stir-frying for some indications.

doi:10.1007/s10068-021-00911-1

Safety

Contraindications

It is not suitable for women in lactation for infant, and its use is cautious in pregnant women.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 189–192.

Side effects

  • Clinically no side effects and very low toxicity.
  • Animal intoxications when used as cattle feed attributed to maltoxin (candicine), a trace depolarizing muscle relaxant in the fibrous roots; content too low to be toxicologically significant.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 397.

⚠ Rule-based cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.

Breastfeeding

Avoid suppresses lactation (esp. high dose)

Cultural and historical

Ming Yi Bie Lu · Southern and Northern dynasties

Records barley (Da Mai) among the grain drugs as sweet and cooling, harmonising the stomach and easing the middle burner - the food-grade reputation from which the malted sprout's medicinal use later separated.

Ben Cao Gang Mu · Ming dynasty

Treats malt (Mai Ya) as the specific drug for dispersing accumulation of rice, flour and fruit foods, and records that it moves stagnant qi in the middle burner. Its effect on the breasts is recorded in the classical literature as dispersing milk and relieving breast distension, which is the traditional statement corresponding to the modern dose-dependent prolactin suppression.

References

  1. Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development. Barley. LactMed, NCBI Bookshelf NBK501827. 2024
  2. Wu Zhiqian; Liang Shuxiao; Zhang Xinyu; Ma Mengting; Sui Zhongquan; Corke Harold. Anti-dyspeptic effects and comparative structural analysis of polysaccharides from hulled and hulless barley-based Hordei Fructus Germinatus. Carbohydrate Polymers. 2026 doi:10.1016/j.carbpol.2026.124892
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice